Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: Up to 5-year results from the daily practice BioDay registry
Zhang, Junfen, Boesjes, Celeste M., Loman, Laura, Kamphuis, Esmé, Romeijn, Margreet L.E., Spekhorst, Lotte S., Haeck, Inge, van der Gang, Lian F., Dekkers, Coco C., van der Rijst, Lisa P., Oosting, Albert J., van Lumig, Paula, van Lynden-van Nes, Anneke M.T., Tupker, Ron A., Nijssen, Annieke, Flinterman, Annebeth, Politiek, Klaziena, Touwslager, Wouter R.H., Christoffers, Wianda A., Stewart, Shiarra M., Kamsteeg, Marijke, de Graaf, Marlies, de Bruin-Weller, Marjolein S., Schuttelaar, Marie-Louise A.
Published in Journal of the American Academy of Dermatology (01.08.2024)
Published in Journal of the American Academy of Dermatology (01.08.2024)
Get full text
Journal Article
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
Boesjes, Celeste M, Kamphuis, Esmé, de Graaf, Marlies, Spekhorst, Lotte S, Haeck, Inge, van der Gang, Lian F, Loman, Laura, Zuithoff, Nicolaas P A, Dekkers, Coco, van der Rijst, Lisa P, Romeijn, Geertruida L E, Oosting, Albert J, Gostynksi, Antoni, van Lynden-van Nes, Anneke M T, Tupker, Ron A, van Tuyll van Serooskerken, Anne-Moon, Flinterman, Annebeth, Politiek, Klaziena, Touwslager, Wouter R H, Christoffers, Wianda A, Stewart, Shiarra M, Kamsteeg, Marijke, Schuttelaar, Marie-Louise A, de Bruin-Weller, Marjolein S
Published in JAMA dermatology (Chicago, Ill.) (07.08.2024)
Published in JAMA dermatology (Chicago, Ill.) (07.08.2024)
Get more information
Journal Article